Arvind Rajpal
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Immunology top 5%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 42
-
- Protein purification and stability 16
- Glycosylation and Glycoproteins Research 10
- Co-authors
- Jaume Pons (18 shared papers)Pavel Strop (34 shared papers)Paul J. Carter (1 shared paper)Yasmina Abdiche (11 shared papers)Jack F. Kirsch (4 shared papers)Kevin C. Lindquist (11 shared papers)Purnima Sundar (6 shared papers)Jacob Glanville (4 shared papers)
- Journals
- mAbs (6 papers)Analytical Chemistry (5 papers)Bioconjugate Chemistry (4 papers)Protein Science (4 papers)Proceedings of the National Academy of Sciences (4 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Arvind Rajpal
55 papers receiving 2.7k citations
Arvind Rajpal's Hit Papers
Peers
Comparison fields: 5 of 109
- Radiology, Nuclear Medicine and Imaging 1.4k
- Immunology 835
- Oncology 582
- Molecular Biology 1.5k
- Biotechnology 124
Countries citing papers authored by Arvind Rajpal
This map shows the geographic impact of Arvind Rajpal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvind Rajpal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvind Rajpal more than expected).
Fields of papers citing papers by Arvind Rajpal
This network shows the impact of papers produced by Arvind Rajpal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvind Rajpal. The network helps show where Arvind Rajpal may publish in the future.
Co-authors
The 25 scholars most cited alongside Arvind Rajpal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 343 | |
| 2 | 2016 | 163 | |
| 3 | 2015 | 157 | |
| 4 | Designing antibodies as therapeutics Hit paper breakdown → | 2022 | 152 |
| 5 | 2012 | 137 | |
| 6 | 2011 | 136 | |
| 7 | 2005 | 114 | |
| 8 | 2012 | 112 | |
| 9 | 2003 | 108 | |
| 10 | 2011 | 91 | |
| 11 | 1999 | 88 | |
| 12 | 2014 | 85 | |
| 13 | 2013 | 82 | |
| 14 | 2016 | 80 | |
| 15 | 2011 | 71 | |
| 16 | 2012 | 66 | |
| 17 | 2013 | 57 | |
| 18 | 2013 | 50 | |
| 19 | 2014 | 50 | |
| 20 | 2017 | 46 |
About Arvind Rajpal
Arvind Rajpal is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology, Immunology, Oncology and Biomedical Engineering, having authored 59 papers that have together received 2.8k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (42 papers), Protein purification and stability (16 papers), Glycosylation and Glycoproteins Research (10 papers), T-cell and B-cell Immunology (10 papers), HER2/EGFR in Cancer Research (9 papers), Immune Cell Function and Interaction (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.4k citations), Immunology (835 citations), Oncology (582 citations), Molecular Biology (1.5k citations) and Biotechnology (124 citations). Arvind Rajpal has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Jaume Pons, Pavel Strop, Paul J. Carter, Yasmina Abdiche, Jack F. Kirsch, Kevin C. Lindquist, Purnima Sundar, Jacob Glanville, Davide Foletti and Wenwu Zhai. Their work appears in journals such as mAbs, Analytical Chemistry, Bioconjugate Chemistry, Protein Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.